Cardiorespiratory development in extremely preterm infants: vulnerability to infection and persistence of events

A O Hofstetter1, L Legnevall, E Herlenius

  • 1Department of Woman and Child Health, Karolinska Institutet, Stockholm, Sweden.

Insights

Extremely preterm infants often experience cardiorespiratory events, which persist beyond term-equivalent age. Infection significantly worsens these events, highlighting the need for continued infant monitoring post-hospitalization.

Area of Science:

  • Neonatal physiology
  • Cardiorespiratory development
  • Preterm infant care

Background:

  • Extremely preterm infants frequently experience cardiorespiratory issues like apnoea, bradycardia, and hypoxemia.
  • Limited longitudinal data exists on cardiorespiratory development in this vulnerable population.

Purpose of the Study:

  • To characterize early, age-dependent changes in cardiorespiratory function in extremely preterm infants.
  • To investigate the influence of disease, postnatal insults, and interventions on cardiorespiratory activity.

Main Methods:

  • Prospective study of 33 infants (23-28 weeks gestational age).
  • Weekly cardiorespiratory monitoring from birth to >45 weeks postconceptional age (PCA).
  • Utilized impedance pneumography, ECG, and pulse oximetry to assess cardiorespiratory activity and events.

Main Results:

  • Analyzed 338 recordings (3236 hours).
  • Heart rate decreased, and O2 saturation improved with age; respiratory rate remained stable.
  • 5973 cardiorespiratory events occurred, decreasing with age but remaining frequent at discharge (mean PCA 38.3 weeks).
  • Infection significantly increased apnoea/hypopnoea and hypoxemia.

Conclusions:

  • Cardiorespiratory events persist beyond term-equivalent age in extremely preterm infants.
  • Infection substantially impacts cardiorespiratory function.
  • Close post-hospitalization surveillance is critical for these infants.
Abstract

Related Concept Videos

Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
Atelectasis II: Pathophysiology01:10

Atelectasis II: Pathophysiology

Atelectasis develops when alveoli lose their air and collapse inward. Because lung tissue is naturally elastic, these air sacs shrink rather than remaining open. Collapsed alveoli are no longer ventilated, reducing their role in gas exchange. Blood flow may continue in these regions, creating a ventilation–perfusion mismatch. Clinical findings include decreased breath sounds, dullness to percussion, reduced chest expansion, and decreased tactile fremitus as sound transmission through collapsed...
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following: